Current & Upcoming Clinical Trials

studies.jpg

Currently Enrolling

Male Hormone Replacement Study

AbbVie: Testosterone replacement therapy for assessment of long-term vascular events and efficacy response in hypogonadal men.

This study will look at the effects of testosterone replacement therapy (TRT) on major adverse cardiovascular events (MACE).


Therapeutic Study

Gilead: A Phase 1B randomized, double-blinded, placebo-controlled, multi-cohort study of the safety, pharmacokinetics, and antiviral activity of GS-6207 administered subcutaneously in HIV-1-infected subjects.

This study is looking at the safety and effects of a new long-acting injectable therapy called a “capsid inhibitor” for treatment of HIV.


Therapeutic Study

Trogarzo Study: A Phase 3 study of the safety of Trogarzo™ administered as an undiluted “IV Push” over a reduced interval in clinically-stable HIV-1 infected Trogarzo™ experienced patients.


UPCOMING TRIALS

  • Upcoming trials with novel antiretroviral Islatravir (Merck MK-8591) for treatment naïve and treatment experienced HIV-1 patients.

  • Upcoming trials with Capsid Inhibitor (Gilead).


Interested in participating in a clinical trial?

Contact us to see if you qualify as a candidate for one of our studies!


STUDIES | ABOUT | OUR TEAM | SPONSORS & CROS | CONTACT

9201 W. Sunset Blvd., Suite 812, Los Angeles, Ca. 90069. Open Monday-Friday, 7:00AM-3:30PM. Phone: 310-550-2271.